Acorn Releases CorCap Pivotal Trial Results, Anticipates 2005 Panel Review
This article was originally published in The Gray Sheet
Executive Summary
Acorn Cardiovascular is planning a 2005 continued access protocol for its CorCap cardiac support device, which the company would like to see incorporated into an FDA-mandated post-market study